Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Spinal Fractures 2Neoplasms 2Multiple Myeloma 2Spinal Diseases 1Solid Tumors 1Prostatic Neoplasms 1Pain 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Vertebroplasty × Clear all
NCT00819832 2023-03-24

Anderson Circulating Tumor Cell Burden (CTCB) Study

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 2 charts

Neoplasms, Spinal Diseases

NCT02376933 2018-11-07

Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer

University of Arizona

Phase NA Terminated
11 enrolled 6 charts
Plasma cell

Multiple Myeloma, Neoplasms, Spinal Fractures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡